WebCurrent Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth … WebBentham Science Publishers. Bentham Science is a science, technology, and medical publisher, providing academic researchers and industrial professionals with the latest …
Pharmaceuticals-2010年Volume 3(7)-美国卫生研究院文献【掌桥 …
WebJan 1, 2024 · Current Cancer Drug Targets, 01 Jan 2024, 19(7): 525-533 DOI: 10.2174/1568009619666181220103714 PMID: 30569855 . Review ... Hence, the TME is … WebJan 1, 2024 · Current Cancer Drug Targets, 01 Jan 2024, 19(7): 525-533 DOI: 10.2174/1568009619666181220103714 PMID: 30569855 . Review ... Hence, the TME is a significant target for cancer therapy via nanoparticles, which can carry different kinds of drugs targeting different types or stages of tumors. The key step of nanotherapy is the … highlights luxemburg
Targeted Therapy Drug List by Cancer Type - NCI - National …
WebCurrent Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang ( UH Drug Discovery Institute). … Web《current cancer drug targets》发布于爱科学网,并永久归类相关sci期刊导航类别中,本站只是硬性分析 "《curr cancer drug tar》" 杂志的可信度。学术期刊真正的价值在于它 … WebThe current review article describes some of these promising anticancer targets that include kinases, tubulin, cancer stem cells, monoclonal antibodies and vascular … highlights luxembourg